Review
Accepted on 12 Dec 2024
Efficacy, Safety and Cost-effectiveness of Obinutuzumab in Patients with Follicular Lymphoma: A Rapid Review
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1426772
Type at least 3 characters
1,977 articles
Articles
Original Research
Published on 12 Dec 2024
Association between anthropometric indices and hypertension: identifying optimal cutoff points for U.S. adults across different populations
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1503059
- 303 views
Original Research
Accepted on 11 Dec 2024
Pharmacists' Perceptions of the New Pharmaceutical Vaccination Service in Romania: A Comprehensive First Two-Years Evaluation
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1476504
Original Research
Accepted on 10 Dec 2024
Correlation Between the White Blood Cell/Platelet Ratio and 28-Day All-Cause Mortality in Cardiac Arrest Patients: A Retrospective Cohort Study Based on Machine Learning
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1527664
Systematic Review
Accepted on 10 Dec 2024
Association between penicillin allergy labels and serious adverse events in hospitalized patients: a systematic review and meta-analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1519522
Original Research
Accepted on 10 Dec 2024
A network comparison on efficacy and safety profiling of PD-1/PD-L1 inhibitors in first-line treatment of advanced non-small cell lung cancer
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1516735
Original Research
Published on 10 Dec 2024
Comparison of intravitreal anti-VEGF agents and oral carbonic anhydrase inhibitors in the treatment of cystoid macular edema secondary to retinitis pigmentosa
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1477889
- 351 views
Perspective
Published on 10 Dec 2024
Reframing risks in rare diseases: economics of networks, spillovers, and scale
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1516725
- 180 views
Review
Accepted on 09 Dec 2024
Comparing efficacy and safety of low-dose versus standard-dose antiplatelet therapy in stroke patients: A meta-analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1484130
Review
Accepted on 09 Dec 2024
Discussion on the optimization of personalized medication using information systems based on pharmacogenomics: an example using colorectal cancer
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1516469
Original Research
Published on 06 Dec 2024
Despite the pandemic: upward trajectories of medication adherence and persistence in patients with dyslipidemia
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1488452
- 190 views
Systematic Review
Accepted on 04 Dec 2024
Ecopharmacovigilance future opportunities and challenges: A scoping review
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1515318
Original Research
Accepted on 03 Dec 2024
Survival Analysis in a Sixteen-Year Cohort of Patients receiving systemic treatment for Follicular Lymphoma in Brazil
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1414244
Original Research
Published on 03 Dec 2024
Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1468435
- 344 views
Review
Published on 02 Dec 2024
Medication adherence in allergic diseases and asthma: a literature review
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1488665
- 570 views
Original Research
Published on 02 Dec 2024
Literature review of the clinical features of sulfasalazine-induced drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome (DRESS/DIHS)
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1488483
- 417 views